Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

All Cause Mortality ◽

Patients With Diabetes ◽

Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis

Expert Review of Cardiovascular Therapy ◽

10.1080/14779072.2020.1826308 ◽

2020 ◽

Vol 18 (12) ◽

pp. 919-930 ◽

Cited By ~ 1

Author(s):

Kevin Bryan Lo ◽

Ruchika Bhargav ◽

Grace Salacup ◽

Jerald Pelayo ◽

Jeri Albano ◽

...

Keyword(s):

Systematic Review ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Faculty Opinions recommendation of The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-Analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.740606767.793587877 ◽

2021 ◽

Author(s):

Luis Ruilope ◽

Enrique Morales

Keyword(s):

Systematic Review ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Acute Kidney Disease ◽

Receptor Blockers ◽

The Impact

Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus

JAMA Internal Medicine ◽

10.1001/jamainternmed.2014.348 ◽

2014 ◽

Vol 174 (5) ◽

pp. 773 ◽

Cited By ~ 149

Author(s):

Jun Cheng ◽

Wen Zhang ◽

Xiaohui Zhang ◽

Fei Han ◽

Xiayu Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Cardiovascular Events ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

All Cause Mortality ◽

Patients With Diabetes ◽

Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID ‐19, inflammation level, severity, and death in patients with COVID ‐19: A rapid systematic review and meta‐analysis

Clinical Cardiology ◽

10.1002/clc.23421 ◽

2020 ◽

Cited By ~ 8

Author(s):

Xiao Liu ◽

Chuyan Long ◽

Qinmei Xiong ◽

Chen Chen ◽

Jianyong Ma ◽

...

Keyword(s):

Systematic Review ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients：A protocol for a systematic review and Meta-analysis

10.37766/inplasy2020.5.0032 ◽

2020 ◽

Author(s):

Jia Yao ◽

Xiayu Gong ◽

Xiaoyan Shi ◽

Simin Fan ◽

Junmin Chen ◽

...

Keyword(s):

Systematic Review ◽

Insulin Resistance ◽

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis

Journal of Clinical Hypertension ◽

10.1111/jch.14329 ◽

2021 ◽

Author(s):

Na Jia ◽

Guifang Zhang ◽

Xuelin Sun ◽

Yan Wang ◽

Sai Zhao ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Systemic Review ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

All Cause Mortality ◽

Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with acute decompensated heart failure: a systematic review and meta-analysis

Expert Review of Cardiovascular Therapy ◽

10.1080/14779072.2021.2004121 ◽

2021 ◽

Author(s):

Jerald Pelayo ◽

Kevin Bryan Lo ◽

Eric Peterson ◽

Carly DeFaria ◽

Atif Nehvi ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Acute Decompensated Heart Failure ◽

Meta Analysis ◽

Decompensated Heart Failure ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials

American Journal of Hypertension ◽

10.1038/ajh.2011.8 ◽

2011 ◽

Vol 24 (5) ◽

pp. 582-590 ◽

Cited By ~ 48

Author(s):

G. Tocci ◽

F. Paneni ◽

F. Palano ◽

S. Sciarretta ◽

A. Ferrucci ◽

...

Keyword(s):

Clinical Trials ◽

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Controlled Clinical Trials ◽

Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke

Journal of Hypertension ◽

10.1097/hjh.0000000000000804 ◽

2016 ◽

Vol 34 (3) ◽

pp. 567-575 ◽

Cited By ~ 2

Author(s):

Chia-Jen Shih ◽

Hung-Ta Chen ◽

Pei-Wen Chao ◽

Shu-Chen Kuo ◽

Szu-Yuan Li ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Cardiac Events ◽

Adverse Cardiac Events ◽

Patients With Diabetes ◽

Receptor Blockers ◽

Prior Stroke

Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis

BMJ ◽

10.1136/bmj.e4260 ◽

2012 ◽

Vol 345 (jul11 1) ◽

pp. e4260-e4260 ◽

Cited By ~ 113

Author(s):

D. Caldeira ◽

J. Alarcao ◽

A. Vaz-Carneiro ◽

J. Costa

Keyword(s):

Systematic Review ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Receptor ◽